HyperVault AI Data Center Limited

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

Acumen Pharmaceuticals faces strategic reset with $78.6m cash after Alzheimer’s drug failure

NRx Pharmaceuticals moves toward ketamine sales after FDA approval of domestic injectable product

Intellect Design Arena (INTELLECT) near Rs 505: Is the 16% share-price crash justified when AI revenue is growing but profits are not?

Affle 3i to acquire Perion for $420m, but its $228m cash balance changes the deal maths

TCS HyperVault plans up to Rs 70,000cr Hyderabad AI campus across 264 acres

Tata Consultancy Services subsidiary HyperVault has secured 264 acres in Hyderabad for an AI data-centre campus of up to 1GW, with HyperVault and its partners expected to invest as much as ₹70,000 crore as the Indian technology group moves deeper from IT services into ownership of artificial intelligence infrastructure.

bySrinath

September 7, 2026

Can AMD and Tata Consultancy Services turn Helios into India’s sovereign AI backbone?

AMD and Tata Consultancy Services unveil Helios AI infrastructure blueprint for India. Discover what it means for sovereign AI and hyperscalers.

bySoujanya Ravi

February 16, 2026

The Latest

Acumen Pharmaceuticals faces strategic reset with $78.6m cash after Alzheimer’s drug failure

NRx Pharmaceuticals moves toward ketamine sales after FDA approval of domestic injectable product

Intellect Design Arena (INTELLECT) near Rs 505: Is the 16% share-price crash justified when AI revenue is growing but profits are not?

Affle 3i to acquire Perion for $420m, but its $228m cash balance changes the deal maths

TCS HyperVault plans up to Rs 70,000cr Hyderabad AI campus across 264 acres

Can AMD and Tata Consultancy Services turn Helios into India’s sovereign AI backbone?

Acumen Pharmaceuticals faces strategic reset with $78.6m cash after Alzheimer’s drug failure

NRx Pharmaceuticals moves toward ketamine sales after FDA approval of domestic injectable product

Intellect Design Arena (INTELLECT) near Rs 505: Is the 16% share-price crash justified when AI revenue is growing but profits are not?

Affle 3i to acquire Perion for $420m, but its $228m cash balance changes the deal maths

SAMILBIO expands Chaeyun skincare with two November launches as K-beauty exports reach $11.1bn

Schneider Electric Infrastructure (SCHNEIDER) shares fall 3.5% despite new factory expansion: What will November results reveal?

Haleon (HLN) near 319p: Does a 15% share-price crash make its valuation attractive after the growth downgrade?

Ethan Allen will split CEO and chair roles, but who gets to choose Farooq Kathwari’s successor?